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 
Abstract— Objective: Proximal and whole-body vibrations are 
well studied in seismocardiography and ballistocardiography, yet 
distal vibrations are still poorly understood. In this paper we 
develop two methods to measure aortic valve opening (AVO) and 
closing (AVC) from distal vibrations. Methods: AVO and AVC 
were detected for each heartbeat with accelerometers on the 
upper arm (A), wrist (W), and knee (K) of 22 consenting adults 
following isometric exercise. Exercise-induced changes were 
recorded with impedance cardiography, and nine-beat ensemble 
averaging was applied. Our first method, FilterBCG, detects 
peaks in distal vibrations after filtering with individually-tuned 
bandpass filters while RidgeBCG uses ridge regression to 
estimate AVO and AVC without peaks. Pseudocode is provided. 
Results: In agreement with recent studies, we did not find peaks 
at AVO and AVC in distal vibrations, and the conventional R-J 
interval method from the literature also correlated poorly with 
AVO (r2 = 0.22 A, 0.14 W, 0.12 K). Interestingly, distal vibrations 
filtered with FilterBCG resembled seismocardiogram signals and 
yielded reliable peaks at AVO (r2 = 0.95 A, 0.94 W, 0.77 K) and 
AVC (r2 = 0.92 A, 0.89 W, 0.68 K). Conclusion: FilterBCG 
measures AVO and AVC accurately from arm, wrist, and knee 
vibrations, and it outperforms R-J intervals and RidgeBCG. 
Significance: To our knowledge, this study is the first to measure 
AVC accurately from distal vibrations. Finally, AVO timing is 
needed to assess cardiovascular disease risk with pulse wave 
velocity (PWV) and for cuff-less diastolic blood pressure 
measurement via aortic pulse-transit time (PTT). 
 
Index Terms—BCG, ballistocardiography; SCG, 
seismocardiography; PTT, pulse transit time; PEP, pre-ejection 
period; PWV, pulse wave velocity 
 
I. INTRODUCTION 
HE timings of aortic valve opening (AVO) and closing 
(AVC) events reveal important physiologic information 
about the performance of the heart. When the occurrence of 
the electrocardiogram (ECG) R-wave is also known, the three 
systolic time intervals – pre-ejection period (PEP), left 
ventricular ejection time (LVET), and total electromechanical 
systole (QS2) – can be found directly from AVO and AVC. 
These time intervals are metrics of cardiac function that are 
clinically useful and can be measured noninvasively [1]–[5]. 
For example, systolic time intervals (STI) have been used to 
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successfully quantify left ventricular (LV) function of healthy 
and diseased myocardia, and reduced LV function was found 
to increase PEP and decrease LVET [2], [3], [5]. More 
recently, STI from tissue Doppler imaging predicted 
rehospitalization of chronic heart failure patients [1]. Other 
noninvasive methods for measuring STI have been studied. 
Classically, STI are determined from an ECG, carotid pulse 
tracing, and phonocardiogram [3]. More recently, 
photoplethysmography and echocardiography have also been 
used to measure STI [6]. Another modern method, impedance 
cardiography (ICG), injects a small current through the upper 
body to measure changes in thoracic blood volume [7]–[9]. 
ICG has been used to distinguish healthy and impaired LV 
function in cases of chronic heart failure [4].  
However, a major drawback of these methods is that each 
requires a proximal measurement to determine PEP. Applied 
distally, they cannot measure PEP because AVO and AVC at 
the periphery necessarily include a propagation delay [6]. This 
is an important problem to address because solving it could 
enable devices to measure blood pressure accurately from 
aortic pulse transit time (PTT) or to assess cardiovascular 
disease (CVD) risk from aortic pulse wave velocity (PWV). 
PTT, the time interval during which a pressure wave travels 
between two locations in the arterial tree, allows detection of 
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Fig. 1. Comparison of wearable pulse transit time (PTT) measurement 
modalities that can potentially be enabled by the technologies described 
in this paper. Distal aortic valve opening detection using 
ballistocardiogram (BCG) signals can even allow, for the first time, the 
measurement of aortic PTT in a knee brace form factor.  
Wearable Pulse Transit Time Modalities Potentially 
Enabled by Distal Aortic Valve Opening Detection
Armband
Wrist Watch
Knee Brace/Wrap
Modality Advantages
 Convenient
 Ubiquitous
 Perfusion ↑ for 
reflective PPG
 Convenient
Motion noise ↓
 Aortic PTT
 PTT ↑ relative 
to the wrist
Disadvantages
 Not aortic PTT
Motion noise ↑
 Strap tightness 
changes signal
 Not aortic PTT
 PTT ↓ relative 
to the wrist
 Less 
convenient
Motion noise ↑
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beat-by-beat changes in blood pressure without a pressure cuff 
[10], [11]. Beat-by-beat sensitivity and lack of a pressure cuff 
are two significant advantages over today’s standard blood 
pressure methods, such as auscultation and oscillometry [12], 
[13]. Although systolic blood pressure may be acquired with 
pulse arrival time without knowledge of any STI, recent 
studies indicate that PEP must be known in order to accurately 
resolve diastolic blood pressure [14], [15]. Also, aortic PWV, 
which is inversely proportional to aortic PTT and can be 
determined similarly once PEP is known, has been discovered 
as a CVD risk factor of high predictive power [16]–[20] and 
may be superior to any other predictor [21]. Thus, a novel 
methodology must be developed before any distally-worn PTT 
or PWV device can be implemented.  
We believe that ballistocardiography (BCG) could meet this 
need. BCG is a time series of small vibrations of the body 
caused by the beating heart [22]. Recently, we conducted the 
first intensive study of BCG applied to PTT and found that 
BCG could be used as a reference for PEP [23]. Conveniently, 
BCG can be measured with a wide variety of sensors [24]–
[30]. When measuring whole-body vibrations with a modified 
weighing scale, the time interval from the ECG R-wave to the 
BCG J-wave, or R-J interval, was found to correlate (r2 = 
0.86) with PEP [31]. This method has become the standard 
method for measuring PEP with any kind of BCG sensor [32]. 
In a different body of research, the vibration sensor is placed 
proximally on the sternum, and the resulting signal is called a 
seismocardiogram (SCG). The resulting time series contain 
peaks at AVO and AVC [33]–[41]. 
However, robust methods for determining AVO and AVC 
when the vibration sensor is worn distally are lacking [26], 
[28], [32]. In previous work, we found that naïve use of R-J 
intervals in distal BCG time series produced poor results, 
although R-J intervals have been widely used this way [32]. 
To address this problem, we developed a system identification 
method to adapt the waveform from a distal accelerometer to 
that of a weighing scale with a filter [42]. A main goal of that 
work was to improve PEP measurements from the standard R-
J interval method of [31]. Although we found that our system 
identification method reduced the standard deviation of PEP 
error by an average of 36.4% in fifteen subjects, the method is 
limited by its need for a simultaneous reference BCG to tune 
the filter. Recently, we showed that a bandpass filter trained 
from ground truth AVO measurements improved PEP in 
recordings without the need for a ground-truth BCG reference 
[43]. However, that method uses the R-J interval technique, 
which can only measure PEP. 
The need for distal capability is not always immediately 
obvious. While capturing an SCG with a device worn on the 
sternum is physically feasible in almost any situation where 
measurement from the arm, wrist, or knee would also be 
possible, there are two major situations where placement on 
the sternum would not be ideal. First, unlike medical devices 
or lab equipment, consumer devices must be both familiar and 
convenient to the user in order to gain widespread adoption. 
There is no existing ubiquitous device we can think of that is 
placed on the sternum. However, wrist watches, exercise 
armbands, and knee braces are all very common consumer 
accessories, and distal methods could be directly applied to 
such devices. Second, measurement of pulse-transit time 
requires knowing when the arterial pulse wave arrives distally 
at the end of a major blood vessel, such as the aorta, as well as 
the proximal timing of the heart. A single device located 
distally at the end of such a blood vessel that measures both 
the pulse wave arrival and the aortic valve opening (AVO) 
would be much more convenient – and less expensive – than 
two separate devices. In the latter case, one device would have 
to be placed at the sternum to capture an SCG along with 
another device worn at the end of the blood vessel, and these 
devices would have to be connected either wirelessly or with a 
cable. This would introduce unnecessary cost and complexity 
over a single-device solution. Fig. 1 summarizes three possible 
measurement systems that could leverage the approaches 
presented in this paper to enable wearable PTT, and even 
wearable aortic PTT, measurement. 
The goal of this work is to develop two new robust methods 
for measuring aortic valve timing from distal vibrations and to 
demonstrate the impact of sensor placement on measurement 
quality. We explain how to measure AVO and AVC – and 
thus LVET and PTT – in time series from an accelerometer 
worn distally on the body. To our knowledge, FilterBCG is the 
first method to accurately detect AVC in distal vibrations. 
Training either method on a subject requires one recording 
with reference AVO and AVC measurements. Also, the 
methods are agnostic to accelerometer orientation until it is 
trained; the user can simply place the sensor on any 
convenient place on the upper body. Finally, we demonstrate 
these techniques on recordings from accelerometers on the 
upper arm, wrist, and knee during post-exercise recovery. This 
work should be valuable to anyone seeking proximal time 
intervals at distal locations on the body, such as researchers of 
BCG, PTT, and PWV. 
II. MATERIALS AND METHODS 
This study was approved by the Institutional Review Board 
of Georgia Institute of Technology (Protocol H13512). 
Twenty-two healthy adults (8 females, 14 males), whose 
detailed demographics appear in Table 1, participated in this 
study. The age distribution of the participants was 23.9 ± 7.5 
years, and the weight distribution was 70.4 ± 13.8 kg. For each 
subject, blood pressure was measured (BP786, Omron 
Corporation, Kyoto, Japan), then the subject performed an 
isometric exercise (wall sit) for two minutes or until 
exhaustion, whichever occurred first. Each subject then stood 
vertically, motionless but relaxed, for a five-minute recovery 
period immediately after the exercise during which the time 
series were recorded. Five minutes was chosen as the 
recording length because it was observed that subjects nearly 
reached their resting PEP by that time. The purpose of the 
protocol was to perturb the system via the exercise 
intervention to acutely reduce PEP and LVET (due to 
increased sympathetic tone during exercise) compared to the 
resting values, and observe the return of both parameters back 
to resting values during recovery.   
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A. Equipment 
A commercial data acquisition system (MP150, BIOPAC 
Systems, Goleta, CA) was used to capture all physiologic 
signals with a standard PC. The physiologic instruments 
consisted of an ECG configured for a modified Lead II 
measurement (BN-EL50 wireless ECG, BIOPAC Systems), an 
8-lead ICG providing a first derivative (dZ/dt) time series 
containing the AVO and AVC ground truth (NICO100C, 
BIOPAC Systems, Goleta, CA), and three triaxial 
accelerometers (3 x 356A32, PCB Piezotronics, Depew, NY) 
that were powered and amplified 100x with three Integrated 
Electronic Piezoelectric (IEPE) signal conditioners (482C05, 
PCB Piezotronics, Depew, NY). Impedance cardiography was 
chosen because it is easier to acquire than echocardiograms, 
which require a trained technician; ICG has been shown to 
measure AVO and AVC well in healthy subjects when 
compared to echocardiography [8], [9]; and ICG has been 
used previously in similar studies [27], [29], [31], [43]–[45]. 
All signals were sampled simultaneously at fs = 2 kHz and 
saved for offline processing in MATLAB (MathWorks, 
Natick, MA). The accelerometers were chosen for their low 
noise properties as described in [46] and were attached 
laterally to the upper arm, wrist, and knee with kinesiology 
tape wrapped around each limb (Kinesio Tex, Kinesio, 
Albuquerque, NM). Since each accelerometer consisted of 
three axes, and simultaneous ECG and ICG recordings were 
also obtained, a total of 11 synchronized time series were 
recorded.  
B. Statistical Methods 
Standard methods from BCG and ICG literature were 
applied. The locations of the ECG R-waves were determined 
with a peak detector and used to segment each BCG and ICG 
recording into individual beats. Then, every nine beats (N = 9) 
in each time series were averaged sample-by-sample to 
generate ensemble averages as in [24], and the B-wave (AVO) 
in each dZ/dt beat was determined using a method we 
described in [43]. The dZ/dt X-wave (AVC) was determined 
as the lowest trough – the standard method in impedance 
cardiography [47] – from 150–330 ms after the B-wave. This 
range corresponds approximately to the expected range of 
LVET for healthy subjects [48], and it covered this dataset. 
Each detected B- and X-wave (AVO and AVC) was then 
inspected manually beat-by-beat to ensure that the ground-
truth was accurate.  
First, a modified version of the standard method to obtain 
AVO from R-J intervals via regression [31] that we first used 
in a recent pilot study [43] was applied to the BCG. The 
difference between the R-J interval method in [31] and that of 
this work is that individual regressions were found from the R-
J intervals of each subject to ground-truth PEP after bandpass 
filtering. Each beat was filtered with a 6th-order Butterworth 
infinite impulse response (IIR) filter in the forward and 
reverse direction to achieve zero phase delay. Then, the filter 
cutoff frequencies, axes (x, y, z), and polarities (non-inverted 
or inverted) of the sensors that resulted in the lowest root 
mean square error (RMSE) after linear regression with 
ground-truth PEP were chosen for each subject and location 
(upper arm, wrist, and knee). The result was a single-axis 
filtered BCG for each location that contained the best possible 
J-wave measurement. 
After determining R-J intervals, a new method called 
FilterBCG was applied to determine AVO and AVC using a 
peak-detection approach similar to standard methods in SCG 
[33], [37], [40], [41]. First, subject-specific IIR bandpass 
filters (6th-order Butterworth IIR, forward and backward) 
were trained to produce peaks between 1–150 ms and 200–475 
ms after the ECG R-wave that resulted in the lowest RMSE 
after regression with ground-truth AVO and AVC, 
respectively. In other words, for each wearable location (upper 
arm, wrist, knee) and event (AVO or AVC) of each subject, 
the bandpass cutoff frequencies, feature type (peak, trough), 
and accelerometer axis (x, y, z) that produced the lowest 
RMSE after regression were selected.  
Figure 2 shows an example of the filtered R-J interval and 
FilterBCG methods applied to vibrations of the wrist for one 
heartbeat aligned with several other time series. Trained IIR 
bandpass filters result in J-waves, AVO peaks, and AVC 
peaks that are more distinct than those appearing in the raw 
BCG waveform. These peaks are then regressed linearly to 
ground-truth AVO (or PEP), AVO, and AVC, respectively. 
Pseudocode for FilterBCG is shown in Figure 3 where the 
inputs are the result from this optimization step. 
TABLE I 
SUBJECT DEMOGRAPHICS 
# Sex Age Weight Height Systolic BP* Diastolic BP* 
0 F 19 yrs 59 kg 165 cm 97 mmHg 75 mmHg 
1 F 19 68 170 93 59 
2 M 20 57 170 100 64 
3 F 18 66 175 100 67 
4 M 33 79 185 144 97 
5 F 23 52 160 96 68 
6 M 25 102 183 146 89 
7 M 33 78 180 122 70 
8 F 19 59 173 103 60 
9 M 24 68 178 121 69 
10 M 23 88 191 126 76 
11 M 20 61 180 117 66 
12 M 31 86 175 131 75 
13 F 49 70 163 118 74 
14 F 16 53 170 120 76 
15 M 31 83 178 100 65 
16 F 23 61 165 104 70 
17 M 19 57 165 93 64 
18 M 19 57 175 113 82 
19 M 22 76 173 104 65 
20 M 20 88 188 114 63 
21 M 20 82 193 113 71 
* BP, blood pressure. 
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Finally, a second new method based on ridge regression 
called RidgeBCG was applied. Unlike the R-J interval and 
FilterBCG methods, RidgeBCG does not choose peaks from 
the vibrations; rather, RidgeBCG determines AVO and AVC 
from all time-domain samples in downsampled beats that are 
located 1–150 ms and 200–475 ms after the ECG R-wave, 
respectively. RidgeBCG is implemented as follows: Before 
ensemble averaging, the BCG time series are filtered 
(bandpass, passband: 0.8–25 Hz, stopband: 35 Hz, 120 dB 
attenuation). The passband must include the cardiogenic 
frequencies of the BCG. Next, the vibrations are sliced at the 
ECG R-waves and ensemble averaged. The samples in 1–150 
ms and 200–475 ms after the ECG R-wave in each beat are 
then taken as the AVO and AVC features, respectively; these 
are the same windows used in ICG and FilterBCG processing. 
The AVO and AVC features of each beat are normalized by 
subtracting the mean and dividing by the standard deviation of 
each beat, and the features are then decimated (downsampled) 
to a lower sampling rate fs. In this study, the original fs was 2 
kHz, the decimation was 28 samples, and the new fs was 71.4 
Hz. This resulted in 11 and 20 samples for AVO and AVC, 
respectively.  
This fs was appropriately chosen because the highest 
frequencies in the BCG signal occur below ~35 Hz. In 
practice, decimation should be applied such that the new fs ≥ 
70 Hz. As an alternative, the accelerometer can be sampled at 
or slightly above 70 Hz if band-limited to ≤ 0.5 fs prior to 
digitization. In such a case, decimation can be omitted. This 
approach would be particularly suitable for low-power 
devices. 
The amplitudes of the decimated samples from each beat 
are then organized into vectors called feature vectors. This 
process is shown in Figure 4. These vectors are then organized 
into AVO and AVC feature matrices where each row is a 
normalized AVO or AVC feature vector from one beat. 
Finally, ridge regression [49] is applied using these matrices 
and AVO and AVC ground-truth measurements. Pseudocode 
for RidgeBCG appears in Figure 5. 
The objective of ridge regression is to find the optimal 
weights, in the L2-norm regularized least-squares sense, which 
can obtain AVO or AVC via a linear combination of the 
entries in each feature vector. Ridge regression has one free 
parameter, λ, which is a scalar that determines the trade-off 
between bias and variance of the resulting measurement. Since 
the number of weights is equal to the number of samples in the 
feature vector, the weights will tend to overfit the data. The 
ridge parameter λ prevents such overfitting. In this work, we 
used the average error of twenty repetitions of two-fold cross 
 
Fig. 2.  Bandpass filtering enhances peaks in a distal vibration heartbeat from 
the wrist. Time series of a phonocardiogram (PCG), electrocardiogram 
(ECG), and impedance cardiogram 1st derivative (ICG dZ/dt) are shown as 
temporal references to the wrist ballistocardiogram (BCG). Three bandpass 
filters are trained on each BCG sensor: one for filtered R-J interval detection 
and two for AVO and AVC detection with FilterBCG. In this example, an 8–
30 Hz passband produced the best R-J intervals, and 18–30 Hz provided the 
best AVO and AVC peaks for FilterBCG. When applied to a distal BCG 
recording, FilterBCG results in a BCG signal resembling an SCG that has two 
peaks coinciding with AVO and AVC.  
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Algorithm FilterBCG 
1: 
2: 
3: 
4: 
5: 
6: 
7: 
8: 
9: 
10: 
11: 
procedure GETVALVEEVENTS(f_lo, f_hi, useMins, type) 
    win  1—150 ms if type is AVO else 200—475 ms. 
    dZdtBeats  ensembleAverage(dZdt, Rwaves, N). 
    bcg  filter(vibrationTimeSeries, bandpass(f_lo, f_hi)). 
    bcgBeats  ensembleAverage(bcg, Rwaves, N). 
    groundTruth  findWaves(dZdtBeats, win). 
    if useMins 
        AVevents  findMinTroughInEachBeat(bcgBeats, win). 
    else 
        AVevents  findMaxPeakInEachBeat(bcgBeats, win). 
    end 
 
Fig. 3.  A pseudocode representation of FilterBCG. The inputs specify the 
passband frequencies, whether to search for minima or maxima, and the type 
of aortic valve event (opening or closing). 
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validation (20 x 2-fold CV) [50]. The error metric used was 
the RMSE of AVO and AVC from RidgeBCG with respect to 
the ICG-derived ground truth AVO and AVC. The best λ of 
the best axis on each accelerometer was then chosen for each 
subject. 
Since the exercise intervention was performed once per 
subject, one dataset was used for both training and testing. 
However, in real use, the training set should be obtained 
before using RidgeBCG. Thus, in order to determine results 
that could be expected in actual use, 20 x 2-fold CV was 
performed a second time to train the method on half of the 
beats and test the method on the others, where the ridge 
regression parameter λ was determined by a previous 20 x 2-
fold CV training step as described earlier. In this paper, the 
results we present for RidgeBCG are the mean across all folds 
in this second CV step. Thus, our results are a conservative 
estimate of RidgeBCG’s performance where overfitting was 
properly minimized. While CV was needed with RidgeBCG to 
prevent overfitting because RidgeBCG has 11 and 20 free 
parameters for AVO and AVC, CV was not used for 
FilterBCG or R-J intervals because the bandpass filter was 
trained on only two parameters – the upper and lower cutoff 
frequencies – which does not tend to overfit the training data. 
III. RESULTS AND DISCUSSION 
The correlations between BCG- and ICG-derived AVO and 
AVC for all subjects and methods are shown in Figure 6 and 
Figure 7. Additionally, Figure 8 quantifies the effect of 
ensemble averaging on the FilterBCG correlations. The latter 
plot can be used to pick a suitable ensemble average length in 
future work. A total of 9648 heart beats from 22 subjects were 
processed, which resulted in 1072 beats after nine-beat 
ensemble averaging. For AVO and AVC from every location 
except the knee, FilterBCG resulted in better correlations than 
R-J intervals, filtered R-J intervals, or RidgeBCG. Filtered R-J 
intervals was the best method at the knee. This could be due to 
more attenuation of higher frequencies used in FilterBCG, 
since the R-J interval relies on lower frequencies to determine 
PEP.  
Overall, the knee was worse than the upper arm and the 
wrist. As shown in Table 2, the within-subject RMSE 
differences of the wrist and upper arm AVO and AVC were 
not significantly significant in paired t-tests, but the wrist and 
knee were significantly different (p < 0.05). We believe that 
the knee was inferior to the wrist and upper arm due to higher 
attenuation of cardiogenic vibrations. Since the feet are 
grounded to a solid surface while standing, attenuation should 
increase, and thus the BCG signal-to-noise ratio (SNR) should 
decrease, as the sensor is worn lower on the body. This could 
be a question for further study. 
Table 2 also shows that the difference between FilterBCG 
and filtered R-J intervals was not statistically significant. 
However, the trained bandpass filter significantly reduced the 
RMSE of each subject in both the FilterBCG and filtered R-J 
interval methods. The trained bandpass filter introduced in this 
paper is therefore a significant improvement over the 
unfiltered R-J intervals method, which is the current standard.  
In the correlation summary in Figure 7, the best axis was 
used. In 41 out of 66 (62%) of the sensors in the study for 22 
subjects and three wearable locations on the body, the best 
axis was the head-to-foot axis. To better understand the impact 
of the physical orientation of the sensor, FilterBCG was 
applied to each of the other two axes as well. In this case, the 
 
Fig. 4.  RidgeBCG feature extraction. Rather than determining AVO and 
AVC from specific features, such as peaks, RidgeBCG measures AVO and 
AVC by downsampling the BCG heartbeats and applying ridge regression to 
feature vectors. These vectors contain the amplitudes of all samples in two 
predefined windows which cover the expected range of AVO and AVC. 
 
 
 
Algorithm RidgeBCG 
1: 
2: 
3: 
4: 
5: 
6: 
7: 
8: 
9: 
10: 
11: 
12: 
13: 
14: 
15: 
16: 
17: 
18: 
eventType  {1–150ms,’B’} if AVO else {200–475ms,’X’}. 
procedure TRAINRIDGEBCG 
    bcg  filter(vibrationTimeSeries, bandpass(0.8–25 Hz)). 
    bcgBeats  ensembleAverage(bcg, Rwaves, N). 
    dZdtBeats  ensembleAverage(dZdt, Rwaves, N). 
    featMatrix  new empty matrix. 
    for beat in bcgBeats 
        featVec  getFeatureVector(beat, eventType). 
        featMatrix.appendRow(featVec). 
    end 
    groundTruth  findWaves(dZdtBeats, eventType). 
    b  ridgeRegression(groundTruth, featMatrix, λ). 
procedure USERIDGEBCG 
    bcg  filter(recentVibrations, bandpass(0.8–25 Hz)). 
    Rw  the most recent N+1 Rwaves. 
    bcgBeat  ensembleAverage(bcg, Rw, N). 
    featVec  getFeatureVector(bcgBeat, eventType). 
    event  dotProduct(featVec, b). 
 
Fig. 5.  Pseudocode for RidgeBCG. RidgeBCG is trained first by applying 
ridge regression to a training set to obtain a vector of weights. After this step, 
AVO or AVC are measured as the dot, or inner, product of these weights with 
the feature vector of any heartbeat. An entry of 1 may need to be inserted at 
the beginning of each vector to accommodate a y-intercept. 
BCG
Normalize & decimate
AVO
1 150 200 475 ms
Feature vectors
AVC
 6 
 
Fig. 6.  Scatterplots of FilterBCG measurements versus an ICG ground-truth for the three accelerometers worn on the body after training. The ICG and vibration 
time series were nine-beat ensemble averaged, and each subject’s ICG measurements were centered about zero before FilterBCG to remove differences between 
the subjects’ AVO and AVC baselines. When intra-subject means are not subtracted, the resulting correlations tend to be optimistic because most of the variance 
is represented by inter-subject spread rather than the method of measurement. 
 
 
 
 
Fig. 7.  Correlations of BCG to ICG for all methods after nine-beat ensemble averaging. R-J intervals do not measure AVC and thus do not appear on the right. 
A key contribution of this paper is the finding that distal wearable ballistocardiograms can measure AVC after bandpass filtering. In the case of the wrist and 
upper arm, such measurements are quite accurate. FilterBCG exceeded other methods in this study. Although filtered R-J intervals did have a higher correlation 
than FilterBCG at the knee, the differences between FilterBCG and filtered R-J intervals were not statistically significant as shown in Table 2. 
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correlations were lower but still strong (AVO: r2 = 0.82 A, 
0.74 W, 0.49 K; AVC: r2 = 0.68 A, 0.58 W, 0.45 K). The 
difference between the best axis and the other axes was 
statistically significant in all cases, and the p-values are shown 
in Table 2. However, the results were still acceptable from the 
suboptimal axes, especially for AVO from the upper arm (r2 = 
0.82). This suggests that it may be possible to obtain 
acceptable results even when the accelerometer is placed 
haphazardly on the body. This is important because single-axis 
accelerometers can be lower in cost and power consumption 
than multi-axis variants, and the ability to place a BCG device 
on the body without great care also simplifies the technique 
for the end-user. Nevertheless, the optimal axis seems to vary 
subject-to-subject and may also depend on precisely how the 
sensor is placed. It therefore appears that better results can be 
obtained with a multi-axis accelerometer in general. 
Developing better methods to combine several BCG axes 
could be a topic of future study. Also, increasing the number 
of axes beyond three, for example with a gyroscope to 
measure angular motion, could also be a topic for future study. 
The principal limitations of FilterBCG and RidgeBCG 
include subject-specific training and requiring the subject to 
reduce body movements during measurements. Subject-
specific training on time series during which AVO and AVC 
are changing is a major inconvenience for users. The vast 
majority of users of wearable devices will have neither 
ground-truth measurements nor the time to perform in-depth 
calibrations for their devices. Future work should focus on 
reducing or eliminating the training step. The latter limitation 
of reducing body movement applies to any method relying on 
small body vibrations, including all techniques in the 
ballistocardiography and seismocardiography literature to 
date. Even standard electrophysiology recordings such as ECG 
and ICG exhibit motion artifacts. The methods in this paper 
are no different; FilterBCG and RidgeBCG cannot be used 
while the subject is moving, for example, during exercise. 
However, measurements can still be made during a rest period 
in the middle of an exercise, and small vibrations, such as 
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from heavy breathing or fatigued muscles, are largely 
eliminated by the ensemble averaging.  
IV. CONCLUSION 
In this paper two new methods to measure AVO and AVC 
from distal body vibrations were demonstrated. Both methods 
exceeded the standard method of R-J intervals in the existing 
literature that uses unfiltered BCG waveforms. This confirms 
our previous findings that R-J intervals do not correlate well to 
ground-truth PEP (AVO) in wearable BCG signals. In general, 
we recommend FilterBCG over all other methods because its 
AVO and AVC measurements correlated the best to an ICG 
ground truth in all but one case which was not statistically 
significant. We also believe that this is the first work to 
demonstrate AVC measurement from distal vibrations thus 
enabling measurements of LVET from distal vibrations for the 
first time. Future work will focus on reducing or eliminating 
the training step, which we believe is the main limitation of 
the methods we present in this paper. In particular, the training 
step requires an ECG and ICG, two signals that a low-cost 
consumer device typically would not have. Additionally, 
further investigation is needed to develop better cuff-less 
blood pressure methods that use distal vibrations as a proximal 
timing reference. Since accurate measurements of AVO 
timing from distal vibrations are now possible, and AVO is 
needed to measure diastolic blood pressure with aortic PTT, 
the efficacy of a cuff-less blood pressure device based on 
distal vibrations and aortic PTT can be demonstrated. 
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